EIA
PBH icon

Emerald Investment Advisers’s Prestige Consumer Healthcare PBH Stock Holding History

Emerald Investment Advisers’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.33M Buy
49,241
+1,927
+4% +$99K 0.15% 175
2026
Q1 		$2.8M Buy
+47,314
New +$3.07M 0.25% 131

Other funds holding PBH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Emerald Investment Advisers's PBH Position: Q2 2026 in Review

Emerald Investment Advisers increased its Prestige Consumer Healthcare (PBH) stake by 4.1% in Q2 2026, buying an estimated $99K and bringing the position to 49,241 shares worth $2.33M. The position accounts for 0.15% of the portfolio, ranked #175.

Emerald Investment Advisers first reported a position in PBH in Q1 2026 and has held it in 2 quarters since. The position peaked at $2.8M in Q1 2026. 318 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Emerald Investment Advisers held 49,241 shares of Prestige Consumer Healthcare worth $2.33M as of Q2 2026.
  • Emerald Investment Advisers bought 1,927 Prestige Consumer Healthcare shares in Q2 2026, an estimated $99K.
  • Prestige Consumer Healthcare made up 0.15% of Emerald Investment Advisers's portfolio in Q2 2026, its #175 holding.
  • Emerald Investment Advisers first reported a position in Prestige Consumer Healthcare in Q1 2026 and has held it in 2 quarters since.
  • Emerald Investment Advisers's Prestige Consumer Healthcare position peaked at $2.8M in Q1 2026.
  • 318 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Emerald Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.